Cargando…

Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report

INTRODUCTION: Drug-induced acute interstitial nephritis (DI-AIN) is an important cause of acute kidney injury. In renal biopsy specimens, tubulitis with eosinophilic infiltration is suggestive of DI-AIN. Although corticosteroid therapy and discontinuation of the offending drug can improve renal dysf...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanabe, Katsuyuki, Matsuoka-Uchiyama, Natsumi, Mifune, Tomoyo, Kawakita, Chieko, Sugiyama, Hitoshi, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678027/
https://www.ncbi.nlm.nih.gov/pubmed/34918693
http://dx.doi.org/10.1097/MD.0000000000028252
_version_ 1784616263335542784
author Tanabe, Katsuyuki
Matsuoka-Uchiyama, Natsumi
Mifune, Tomoyo
Kawakita, Chieko
Sugiyama, Hitoshi
Wada, Jun
author_facet Tanabe, Katsuyuki
Matsuoka-Uchiyama, Natsumi
Mifune, Tomoyo
Kawakita, Chieko
Sugiyama, Hitoshi
Wada, Jun
author_sort Tanabe, Katsuyuki
collection PubMed
description INTRODUCTION: Drug-induced acute interstitial nephritis (DI-AIN) is an important cause of acute kidney injury. In renal biopsy specimens, tubulitis with eosinophilic infiltration is suggestive of DI-AIN. Although corticosteroid therapy and discontinuation of the offending drug can improve renal dysfunction in most cases of DI-AIN, some patients experience AIN recurrence, leading to corticosteroid dependency. Corticosteroid-dependent eosinophilic interstitial nephritis presents a difficult dilemma in diagnosis and information regarding optimum management is limited. PATIENT CONCERNS: A 25-year-old man, who received treatment with carbamazepine, zonisamide, valproate, and lacosamide for temporal lobe epilepsy, showed an increase in serum creatinine level from 0.98 to 1.29 mg/dL over a period of 6 months. Although he exhibited no symptoms, his serum creatinine level continued to increase to 1.74 mg/dL. DIAGNOSIS: Renal biopsy revealed tubulitis and interstitial inflammatory infiltrates with eosinophils. Immunological and ophthalmological examinations showed no abnormal findings, and thus, his renal dysfunction was presumed to be caused by DI-AIN. Although oral prednisolone (PSL) administration (40 mg/d) and discontinuation of zonisamide immediately improved his renal function, AIN recurred 10 months later. The increase in PSL dose along with discontinuation of valproate and lacosamide improved renal function. However, 10 months later, recurrent AIN with eosinophilic infiltration was confirmed by further biopsy. The patient was therefore diagnosed with corticosteroid-dependent eosinophilic interstitial nephritis. INTERVENTIONS: To prevent life-threatening epilepsy, carbamazepine could not be discontinued; hence, he was treated with an increased dose of PSL (60 mg/d) and 1500 mg/d of mycophenolate mofetil (MMF). OUTCOMES: MMF was well tolerated and PSL was successfully tapered to 5 mg/d; renal function stabilized over a 20-month period. LESSONS: The presence of underdetermined autoimmune processes and difficulties in discontinuing the putative offending drug discontinuation are contributing factors to corticosteroid dependency in patients with eosinophilic interstitial nephritis. MMF may be beneficial in the management of corticosteroid-dependent eosinophilic interstitial nephritis by reducing the adverse effects related to high-dose and long-term corticosteroid use.
format Online
Article
Text
id pubmed-8678027
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86780272021-12-20 Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report Tanabe, Katsuyuki Matsuoka-Uchiyama, Natsumi Mifune, Tomoyo Kawakita, Chieko Sugiyama, Hitoshi Wada, Jun Medicine (Baltimore) 5200 INTRODUCTION: Drug-induced acute interstitial nephritis (DI-AIN) is an important cause of acute kidney injury. In renal biopsy specimens, tubulitis with eosinophilic infiltration is suggestive of DI-AIN. Although corticosteroid therapy and discontinuation of the offending drug can improve renal dysfunction in most cases of DI-AIN, some patients experience AIN recurrence, leading to corticosteroid dependency. Corticosteroid-dependent eosinophilic interstitial nephritis presents a difficult dilemma in diagnosis and information regarding optimum management is limited. PATIENT CONCERNS: A 25-year-old man, who received treatment with carbamazepine, zonisamide, valproate, and lacosamide for temporal lobe epilepsy, showed an increase in serum creatinine level from 0.98 to 1.29 mg/dL over a period of 6 months. Although he exhibited no symptoms, his serum creatinine level continued to increase to 1.74 mg/dL. DIAGNOSIS: Renal biopsy revealed tubulitis and interstitial inflammatory infiltrates with eosinophils. Immunological and ophthalmological examinations showed no abnormal findings, and thus, his renal dysfunction was presumed to be caused by DI-AIN. Although oral prednisolone (PSL) administration (40 mg/d) and discontinuation of zonisamide immediately improved his renal function, AIN recurred 10 months later. The increase in PSL dose along with discontinuation of valproate and lacosamide improved renal function. However, 10 months later, recurrent AIN with eosinophilic infiltration was confirmed by further biopsy. The patient was therefore diagnosed with corticosteroid-dependent eosinophilic interstitial nephritis. INTERVENTIONS: To prevent life-threatening epilepsy, carbamazepine could not be discontinued; hence, he was treated with an increased dose of PSL (60 mg/d) and 1500 mg/d of mycophenolate mofetil (MMF). OUTCOMES: MMF was well tolerated and PSL was successfully tapered to 5 mg/d; renal function stabilized over a 20-month period. LESSONS: The presence of underdetermined autoimmune processes and difficulties in discontinuing the putative offending drug discontinuation are contributing factors to corticosteroid dependency in patients with eosinophilic interstitial nephritis. MMF may be beneficial in the management of corticosteroid-dependent eosinophilic interstitial nephritis by reducing the adverse effects related to high-dose and long-term corticosteroid use. Lippincott Williams & Wilkins 2021-12-17 /pmc/articles/PMC8678027/ /pubmed/34918693 http://dx.doi.org/10.1097/MD.0000000000028252 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 5200
Tanabe, Katsuyuki
Matsuoka-Uchiyama, Natsumi
Mifune, Tomoyo
Kawakita, Chieko
Sugiyama, Hitoshi
Wada, Jun
Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report
title Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report
title_full Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report
title_fullStr Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report
title_full_unstemmed Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report
title_short Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report
title_sort management of corticosteroid-dependent eosinophilic interstitial nephritis: a case report
topic 5200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678027/
https://www.ncbi.nlm.nih.gov/pubmed/34918693
http://dx.doi.org/10.1097/MD.0000000000028252
work_keys_str_mv AT tanabekatsuyuki managementofcorticosteroiddependenteosinophilicinterstitialnephritisacasereport
AT matsuokauchiyamanatsumi managementofcorticosteroiddependenteosinophilicinterstitialnephritisacasereport
AT mifunetomoyo managementofcorticosteroiddependenteosinophilicinterstitialnephritisacasereport
AT kawakitachieko managementofcorticosteroiddependenteosinophilicinterstitialnephritisacasereport
AT sugiyamahitoshi managementofcorticosteroiddependenteosinophilicinterstitialnephritisacasereport
AT wadajun managementofcorticosteroiddependenteosinophilicinterstitialnephritisacasereport